Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin

European Journal of Pharmacology
T UngerD Ganten

Abstract

The role of the sympathetic nervous system and of arginine vasopressin (AVP) in the mediation of the central cardiovascular effects of angiotensin II (ANG II) and substance P (SP) was investigated. ANG II and SP caused dose-dependent blood pressure increases when injected into the lateral brain ventricle (i.c.v.) of conscious rats; ANG II was tenfold more potent than SP. Peripheral blockade of alpha-adrenoceptors with prazosin or blockade of the vasopressor action of AVP by the AVP antagonist d(CH2)5VDAVP both partially inhibited the pressor responses to central ANG II. Combined treatment with the two blockers produced almost complete inhibition of the central ANG I responses. Substance P injected i.c.v. produced increases in noradrenaline and adrenaline but not AVP in the plasma. Peripheral alpha-receptor blockade by prazosin reversed the central pressor effects of SP to depressor responses. The AVP antagonist did not alter the cardiovascular responses to SP. It is concluded that in conscious animals, stimulation of the sympathetic nervous system and release of AVP contribute to the central pressor action of ANG II to a similar extent and independently of each other. In contrast, the central pressor responses to SP appear to b...Continue Reading

References

Apr 1, 1975·Endocrinology·L C KeilW B Severs
Feb 22, 1978·Pflügers Archiv : European journal of physiology·D Haack, J Möhring
Jan 1, 1971·Pharmacology·W B SeversJ D Connor
Jan 1, 1980·British Journal of Pharmacology·M BelletH Schmitt
Nov 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·G Haeusler, R Osterwalder

❮ Previous
Next ❯

Citations

Jan 1, 1989·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·R RettigM P Printz
Jan 1, 1989·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·R RettigM Intaglietta
Jun 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·N V KomissarovaK D Jentzsch
Jun 1, 1989·Biulleten' eksperimental'noĭ biologii i meditsiny·S I Kashtanov
May 16, 1983·Brain Research·T J Brennan, J R Haywood
May 1, 1989·Brain Research·T UngerP Rohmeiss
Aug 17, 1984·European Journal of Pharmacology·T J BrennanJ R Haywood
Jun 7, 1985·European Journal of Pharmacology·M A PettyD Ganten
Nov 12, 1986·European Journal of Pharmacology·B SchneiderT Unger
Jan 1, 1989·Brain Research. Brain Research Reviews·S M Gardiner, T Bennett
Sep 1, 1992·Brain Research. Brain Research Reviews·J W Wright, J W Harding
Feb 1, 1987·Journal of the Autonomic Nervous System·K YashpalJ L Henry
Jan 31, 2004·European Journal of Pharmacology·Andrée LessardRéjean Couture
Dec 14, 2002·Brain, Behavior, and Immunity·Paul H Black
May 1, 2012·TheScientificWorldJournal·Marisa RossoMichael Berger
Sep 1, 1996·Clinical and Experimental Pharmacology & Physiology·M J McKinleyB J Oldfield
Jul 22, 1993·Annals of the New York Academy of Sciences·H S Chowdrey, S L Lightman
Dec 29, 1995·Annals of the New York Academy of Sciences·J CulmanT Unger
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·M SchinkeM Bader

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.